Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/44730
Full metadata record
DC FieldValueLanguage
dc.contributor.authorModi, Natansh D.-
dc.contributor.authorSwain, Sandra M.-
dc.contributor.authorBUYSE, Marc-
dc.contributor.authorKuderer, Nicole M.-
dc.contributor.authorRowland, Andrew-
dc.contributor.authorRockhold, Frank W.-
dc.contributor.authorSorich, Michael J.-
dc.contributor.authorHopkins, Ashley M.-
dc.date.accessioned2024-11-29T11:01:21Z-
dc.date.available2024-11-29T11:01:21Z-
dc.date.issued2024-
dc.date.submitted2024-11-25T11:55:17Z-
dc.identifier.citationJournal of clinical oncology, 42 (32) , p. 3773 -3777-
dc.identifier.urihttp://hdl.handle.net/1942/44730-
dc.description.abstractUnlocking the full potential of clinical trials through comprehensive CSR and IPD sharing can revolutionize cancer care, enhance safety evaluations, and reduce bias in systematic reviews. It is time for all stakeholders to embrace transparency and advance patient-centered outcomes.-
dc.description.sponsorshipNational Health and Medical Research Council (NHMRC) Postgraduate-
dc.language.isoen-
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-
dc.subject.otherHumans-
dc.subject.otherUnited States-
dc.subject.otherNeoplasms-
dc.subject.otherClinical Trials as Topic-
dc.subject.otherUnited States Food and Drug Administration-
dc.subject.otherAntineoplastic Agents-
dc.subject.otherDrug Approval-
dc.titleClinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data Availability-
dc.typeJournal Contribution-
dc.identifier.epage3777-
dc.identifier.issue32-
dc.identifier.spage3773-
dc.identifier.volume42-
local.format.pages6-
local.bibliographicCitation.jcatA2-
dc.description.notesHopkins, AM (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, Australia.-
dc.description.notesashley.hopkins@flinders.edu.au-
local.publisher.placeTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA-
local.type.refereedRefereed-
local.type.specifiedEditorial Material-
local.classdsPublValOverrule/author_version_not_expected-
dc.identifier.doi10.1200/JCO.24.00539-
dc.identifier.pmid38917375-
dc.identifier.isi001348825000018-
dc.contributor.orcidModi, Natansh/0000-0003-3262-5374-
local.provider.typewosris-
local.description.affiliation[Modi, Natansh D.; Rowland, Andrew; Sorich, Michael J.; Hopkins, Ashley M.] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, Australia.-
local.description.affiliation[Swain, Sandra M.] MedStar Hlth, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA.-
local.description.affiliation[Buyse, Marc] Hasselt Univ, Int Drug Dev Inst IDDI, Hasselt, Belgium.-
local.description.affiliation[Buyse, Marc] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium.-
local.description.affiliation[Kuderer, Nicole M.] Adv Canc Res Grp, Kirkland, WA USA.-
local.description.affiliation[Rockhold, Frank W.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA.-
local.uhasselt.internationalyes-
item.accessRightsClosed Access-
item.contributorModi, Natansh D.-
item.contributorSwain, Sandra M.-
item.contributorBUYSE, Marc-
item.contributorKuderer, Nicole M.-
item.contributorRowland, Andrew-
item.contributorRockhold, Frank W.-
item.contributorSorich, Michael J.-
item.contributorHopkins, Ashley M.-
item.fullcitationModi, Natansh D.; Swain, Sandra M.; BUYSE, Marc; Kuderer, Nicole M.; Rowland, Andrew; Rockhold, Frank W.; Sorich, Michael J. & Hopkins, Ashley M. (2024) Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data Availability. In: Journal of clinical oncology, 42 (32) , p. 3773 -3777.-
item.fulltextNo Fulltext-
crisitem.journal.issn0732-183X-
crisitem.journal.eissn1527-7755-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.